Browse Anti-HIV agents topic

Evaluation subtopic

Articles 1-16 out of 16 article(s) Title Author Type Date Words Revised U.S. Adult and Adolescent Antiretroviral Treatment Guidelines; also Revised Pediatric Guidelines. James, John S. Nov 28, 2003 347 Lexiva[TM] (Fosamprenavir) approved. Brief Article Oct 31, 2003 197 Treatment interruption: study found poor result for highly treated, highly resistant patients. James, John S. Sep 12, 2003 573 New protease inhibitor atazanavir (Reyataz[TM]) approved. Jun 27, 2003 436 Abacavir arm stopped in clinical trial. James, John S. Apr 4, 2003 548 Basic science priorities for therapeutics research. Bridges, Sandra Mar 22, 2003 1213 Prevention: New approach will test tenofovir for persons at high risk. James, John S. Brief Article Nov 22, 2002 199 T-20 (FUZEON) gets priority review. Brief Article Oct 18, 2002 173 ACTG 384 at Barcelona: the bottom line. James, John S. Aug 9, 2002 453 Retroviruses conference: Some new drugs in the pipeline. James, John S. Apr 12, 2002 1727 Fact sheet: viread: viread is supplied in 300 mg tablets that are almond shaped, light blue film coated, and embossed with "Gilead" and "4331" on one side and with "300" on the other side. Product/Service Evaluation Apr 1, 2002 439 New kinds of treatment. Jan 25, 2002 476 AIDS and Hepatitis News from ICAAC Conference: Phone Overview, Web Reports. Dec 21, 2001 210 Protease inhibitors in children: combination therapy reduced death by two thirds. James, John S. Nov 23, 2001 573 Don't flip over blips. (Bottom Lines). Brief Article Jul 1, 2001 225 Approved Drugs for HIV/AIDS or AIDS-related Conditions. Pamphlet Jul 6, 1999 1520